Xilio Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Xilio Therapeutics, Inc. reported Earnings Per Share Diluted of $4.19 (loss) per share for the year ending 2025.

  • Xilio Therapeutics, Inc. showed an increase of +72.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Xilio Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Xilio Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 96.0%.
  • Historical annual values: Fiscal year 2025: $4.19 (loss) per share | Fiscal year 2024: $15.24 (loss) per share | Fiscal year 2023: $2.78 (loss) per share | Fiscal year 2022: $3.22 (loss) per share | Fiscal year 2021: $13.52 (loss) per share | Fiscal year 2020: $105.42 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: